Negar Pourjamal
Overview
Explore the profile of Negar Pourjamal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pourjamal N, Le Joncour V, Vereb G, Honkamaki C, Isola J, Leyton J, et al.
Transl Oncol
. 2025 Jan;
53:102284.
PMID: 39837059
Background: Most HER2-positive breast or gastric cancers eventually become resistant to the approved anti-HER2 antibody-drug conjugates (ADC) trastuzumab emtansine (T-DM1) and trastuzumab deruxtecan (T-DXd). Disitamab vedotin (DV) is a novel...
2.
Halme A, Laakkonen S, Rutanen J, Nevalainen O, Sinisalo M, Horstia S, et al.
J Infect
. 2024 Jul;
89(3):106217.
PMID: 38969238
Objectives: We studied the short- and long-term effects of imatinib in hospitalized COVID-19 patients. Methods: Participants were randomized to receive standard of care (SoC) or SoC with imatinib. Imatinib dosage...
3.
Pourjamal N, Yazdi N, Halme A, Le Joncour V, Laakkonen P, Saharinen P, et al.
Clin Exp Metastasis
. 2024 Feb;
41(2):91-102.
PMID: 38367127
Human epidermal growth factor 2 (HER2)-positive breast cancer with lung metastases resistant to targeted agents is a common therapeutic challenge. Absence of preclinical lung metastasis models that are resistant to...
4.
Lavikainen L, Guyatt G, Kalliala I, Cartwright R, Luomaranta A, Vernooij R, et al.
Am J Obstet Gynecol
. 2023 Dec;
230(4):390-402.
PMID: 38072372
Objective: This study aimed to provide procedure-specific estimates of the risk for symptomatic venous thromboembolism and major bleeding in noncancer gynecologic surgeries. Data Sources: We conducted comprehensive searches on Embase,...
5.
Lavikainen L, Guyatt G, Luomaranta A, Cartwright R, Kalliala I, Couban R, et al.
Am J Obstet Gynecol
. 2023 Oct;
230(4):403-416.
PMID: 37827272
Objective: This study aimed to provide procedure-specific estimates of the risk of symptomatic venous thromboembolism and major bleeding in the absence of thromboprophylaxis, following gynecologic cancer surgery. Data Sources: We...
6.
Lavikainen L, Guyatt G, Sallinen V, Karanicolas P, Couban R, Singh T, et al.
Ann Surg
. 2023 Aug;
279(2):213-225.
PMID: 37551583
Objective: To provide procedure-specific estimates of symptomatic venous thromboembolism (VTE) and major bleeding after abdominal surgery. Background: The use of pharmacological thromboprophylaxis represents a trade-off that depends on VTE and...
7.
Singh T, Lavikainen L, Halme A, Aaltonen R, Agarwal A, Blanker M, et al.
Br J Surg
. 2023 Mar;
110(5):553-561.
PMID: 36912116
Background: The timing at which venous thromboembolism (VTE) occurs after major surgery has major implications for the optimal duration of thromboprophylaxis. The aim of this study was to perform a...
8.
Nevalainen O, Horstia S, Laakkonen S, Rutanen J, Mustonen J, Kalliala I, et al.
Nat Commun
. 2022 Oct;
13(1):6152.
PMID: 36257950
We report the first long-term follow-up of a randomized trial (NCT04978259) addressing the effects of remdesivir on recovery (primary outcome) and other patient-important outcomes one year after hospitalization resulting from...
9.
Pourjamal N, Lavikainen L, Halme A, Cartwright R, Ahopelto K, Guyatt G, et al.
BJS Open
. 2022 Oct;
6(5).
PMID: 36205224
No abstract available.
10.
Lavikainen L, Guyatt G, Lee Y, Couban R, Luomaranta A, Sallinen V, et al.
Syst Rev
. 2021 Oct;
10(1):264.
PMID: 34625092
Background: Venous thromboembolism (VTE) and bleeding are serious and potentially fatal complications of surgical procedures. Pharmacological thromboprophylaxis decreases the risk of VTE but increases the risk of major post-operative bleeding....